ArticleFrontiers in pharmacology2021

Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels.

Meichen Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.